Deferred Tax Assets, Valuation Allowance of Amphastar Pharmaceuticals, Inc. from 30 Apr 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD and EUR
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Amphastar Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 30 Apr 2014 to 31 Dec 2025.
  • Amphastar Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $23,273,000, a 3.9% increase year-over-year.
Amphastar Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance in EUR history and change rate from 30 Apr 2014 to 31 Dec 2025.
  • Amphastar Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 30 Apr 2014 was €3,200,000.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)
Deferred Tax Assets, Valuation Allowance, Quarterly (EUR)

Amphastar Pharmaceuticals, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $23,273,000 +$879,000 +3.9% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q4 2024 $22,394,000 +$1,899,000 +9.3% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q4 2023 $20,495,000 +$795,000 +4% 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q4 2022 $19,700,000 +$2,819,000 +17% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q4 2021 $16,881,000 +$1,101,000 +7% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q4 2020 $15,780,000 +$5,342,000 +51% 31 Dec 2020 10-K 11 Mar 2022 2021 FY
Q4 2019 $10,438,000 +$1,335,000 +15% 31 Dec 2019 10-K 15 Mar 2021 2020 FY
Q4 2018 $9,103,000 +$4,196,000 +86% 31 Dec 2018 10-K 16 Mar 2020 2019 FY
Q4 2017 $4,907,000 +$1,863,000 +61% 31 Dec 2017 10-K 15 Mar 2019 2018 FY
Q4 2016 $3,044,000 +$2,144,000 +238% 31 Dec 2016 10-K 14 Mar 2018 2017 FY
Q4 2015 $900,000 -$2,962,000 -77% 31 Dec 2015 10-K 15 Mar 2019 2018 FY
Q4 2014 $3,862,000 31 Dec 2014 10-K 15 Mar 2016 2015 FY
Q1 2014 $4,400,000 30 Apr 2014 10-K 15 Mar 2017 2016 FY

Amphastar Pharmaceuticals, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (EUR)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2014 €3,200,000 30 Apr 2014 10-K 15 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.